In the private insurance market, 57.4 million adults under 65 could be potentially eligible for GLP-1 drugs Over 2 in 5 (42%) adults under 65 with private insurance could be eligible for GLP-1 drugs, based on current Food and Drug Administration (FDA) indications
During COVID-19, the manufacturers of insulin drugs worked with local governments to provide insulin drugs to diabetes patients
Yale Center for Perinatal, Pediatric, and Environmental Epidemiology [Editors note: This story was updated to reflect additional information after the U.S
Platelet lysosomes also represent a category of secretory vesicle that contain numerous hydrolytic enzymes
However, for individuals with severe obesity or medical conditions requiring rapid weight loss, surgery may still be necessary
They help regulate blood sugar